Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline
Alzheimer's & Dementia · 2025-06 · 21 (6)
DOI: 10.1002/alz.70351 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 24.06.2025. Verfasst von Rachel A Whitmer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of California Davis, Davis, California, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Life Style, Risk Reduction Behavior. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: U.S. POINTER, NIA NIH HHS.
Abstract (Originalsprache)
INTRODUCTION The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a 2‐year randomized controlled trial of two lifestyle interventions in 2111 older adults at increased risk for cognitive decline. METHODS Sociodemographic and clinical characteristics and rates of ancillary study participation were described with means and frequencies. RESULTS U.S. POINTER successfully enrolled a cohort, ages 60–79 years, which was ethno‐racially inclusive (>30% individuals from groups often under‐represented in clinical trials with cognitive outcomes) and 18% residing in neighborhoods with moderate or high levels of socioeconomic deprivation. Enrollees were cognitively intact but at increased risk for cognitive decline. Participation in ancillary studies (overall 73%) was uniformly high across sociodemographic groups. DISCUSSION The trial cohort meets study goals and provides a basis for assessing multidomain lifestyle intervention effects on cognitive function and other health outcomes that will generalize to large portions of the at‐risk US populations. CLINICALTRIALS.GOV IDENTIFIER NCT00017953. HIGHLIGHTS The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) enrolled individuals at enhanced risk for cognitive decline. Efforts to engage socio‐demographically representative individuals were successful. Four ancillary studies with high rate of recruitment extend scientific impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health Sciences, University of California Davis, Davis, California, USA.
- Department of Internal Medicine, Wake Forest University School of Medicine, The Sticht Center for Healthy Aging and Alzheimer's Prevention, -Salem, Winston, North Carolina, USA.
- Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Alzheimer's Association, Medical and Scientific Relations, Alzheimer's Association, Chicago, Illinois, USA.
- Department of Neuropsychiatry, Advocate Health, Chicago, Illinois, USA.
- Division of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Förderung
- U.S. POINTER
- NIA NIH HHS
Zitieren
APA
Whitmer, R. A., Baker, L. D., Carrillo, M. C., Snyder, H. M., Cleveland, M. L., Gitelman, D. R., Kivipelto, M., Leng, X. I., Lovato, L., Papp, K. V., Pavlik, V. N., Salloway, S. P., Tangney, C. C., Farias, S. T., Williamson, J. D., Wilmoth, S., Woolard, N., Yu, M., Espeland, M. A., & U.S. POINTER Study Group (2025). Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline. Alzheimer's & Dementia, 21(6). https://doi.org/10.1002/alz.70351
Vancouver
Whitmer RA, Baker LD, Carrillo MC, Snyder HM, Cleveland ML, Gitelman DR, et al. Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline. Alzheimer's & Dementia. 2025;21(6). doi:10.1002/alz.70351
BibTeX
@article{Whitmer2025,
author = {Whitmer, Rachel A and Baker, Laura D and Carrillo, Maria C and Snyder, Heather M and Cleveland, MaryJo L and Gitelman, Darren R and Kivipelto, Miia and Leng, Xiaoyan I and Lovato, Laura and Papp, Kathryn V and Pavlik, Valory N and Salloway, Stephen P and Tangney, Christy C and Farias, Sarah Tomaszewski and Williamson, Jeff D and Wilmoth, Sharon and Woolard, Nancy and Yu, Melissa and Espeland, Mark Andrew and U.S. POINTER Study Group, U.S. POINTER Study Group},
title = {Baseline characteristics of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER): Successful enrollment of a diverse clinical trial cohort at risk for cognitive decline},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {6},
doi = {10.1002/alz.70351}
}
EUVIMED